Pavkov, Meda E.

IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., Mbanya, J. C., et al. (2022) · Diabetes Research and Clinical Practice

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 10,123

Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants

Zhou, B., Rayner, A. W., Gregg, E. W., Sheffer, K. E., Carrillo-Larco, R. M., Bennett, J. E., Shaw, J. E., Paciorek, C. J., Singleton, R. K., Barradas Pires, A., et al. (2024) · The Lancet

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 1,013

The Global Epidemiology of Diabetes and Kidney Disease

Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E. (2018) · Advances in Chronic Kidney Disease

Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 686

The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Shlipak, M. G., Tummalapalli, S. L., Boulware, L. E., Grams, M. E., Ix, J. H., Jha, V., Kengne, A.-P., Madero, M., Mihaylova, B., Tangri, N., et al. (2021) · Kidney International

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 581

A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes

Niewczas, M. A., Pavkov, M. E., Skupien, J., Smiles, A., Md Dom, Z. I., Wilson, J. M., Park, J., Nair, V., Schlafly, A., Saulnier, P.-J., et al. (2019) · Nature Medicine

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 432

Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes

Plantinga, L. C., Crews, D. C., Coresh, J., Miller, E. R., Saran, R., Yee, J., Hedgeman, E., Pavkov, M., Eberhardt, M. S., Williams, D. E., et al. (2010) · Clinical Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 408

Trends in incidence of total or type 2 diabetes: systematic review

Magliano, D. J., Islam, R. M., Barr, E. L. M., Gregg, E. W., Pavkov, M. E., Harding, J. L., Tabesh, M., Koye, D. N., & Shaw, J. E. (2019) · BMJ

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 346

The Future Burden of CKD in the United States: A Simulation Model for the CDC CKD Initiative

Hoerger, T. J., Simpson, S. A., Yarnoff, B. O., Pavkov, M. E., Ríos Burrows, N., Saydah, S. H., Williams, D. E., & Zhuo, X. (2015) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 299

Incidence of chronic kidney disease among adults with diabetes, 2015-2020

Tuttle, K. R., Jones, C. R., Daratha, K. B., Koyama, A. K., Nicholas, S. B., Alicic, R. Z., Duru, O. K., Neumiller, J. J., Norris, K. C., Ríos Burrows, N., et al. (2022) · New England Journal of Medicine

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 109

Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

NCD Risk Factor Collaboration (NCD-RisC), Zhou, B., Sheffer, K. E., Bennett, J. E., Gregg, E. W., Danaei, G., Singleton, R. K., Shaw, J. E., Mishra, A., Lhoste, V. P. F., et al. (2023) · Nature Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 94

Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data

Magliano, D. J., Chen, L., Carstensen, B., Gregg, E. W., Pavkov, M. E., Salim, A., Andes, L. J., Balicer, R., Baviera, M., Chan, J. C. N., et al. (2022) · The Lancet Diabetes & Endocrinology

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 91

Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts

Ruiz, P. L. D., Chen, L., Morton, J. I., Salim, A., Carstensen, B., Gregg, E. W., Pavkov, M. E., Mata-Cases, M., Mauricio, D., Nichols, G. A., et al. (2022) · Diabetologia

Diabetes Management and ResearchDiabetes and associated disorders

Cited by 68

The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease

Initiative, O. B. O. T. C. F. D. C. A. P. C., Yarnoff, B. O., Hoerger, T. J., Simpson, S. K., Leib, A., Burrows, N. R., Shrestha, S. S., & Pavkov, M. E. (2017) · BMC Nephrology

Health Systems, Economic Evaluations, Quality of LifeChronic Kidney Disease and Diabetes

Cited by 55

US Trends in Hospitalizations for Dialysis-Requiring Acute Kidney Injury in People With Versus Without Diabetes

Harding, J. L., Li, Y., Burrows, N. R., Bullard, K. M., & Pavkov, M. E. (2020) · American Journal of Kidney Diseases

Acute Kidney Injury ResearchChronic Kidney Disease and Diabetes

Cited by 46

Prevalence of Diabetic Retinopathy and Associated Mortality Among Diabetic Adults With and Without Chronic Kidney Disease

Pavkov, M. E., Harding, J. L., Chou, C.-F., & Saaddine, J. B. (2019) · American Journal of Ophthalmology

Retinal Diseases and TreatmentsChronic Kidney Disease and Diabetes

Cited by 31

Racial Disparities in SGLT2 Inhibitor (SGLT2i) and Glucagon-Like Peptide 1 Receptor Agonist (GLP-1 RA) Use in the US Military Health System (MHS): TH-PO1013

Oliver, J. D., Nee, R., Marneweck, H., Banaag, A., Xu, F., Koyama, A. K., Miyamoto, Y., Pavkov, M. E., & Koehlmoos, T. L. (2024) · Journal of the American Society of Nephrology

Diabetes Treatment and ManagementHealth disparities and outcomes

Cited by 1